Genetic variation in immune function and susceptibility to human filariasis

Expert Review of Molecular Diagnostics

Volumn 3, Issue 3, 2003, Pages 367-374

  Choi, Eun Hwa ^a   Nutman, Thomas B ^b   Chanock, Stephen J ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

Genetic association studies; Genetic susceptability; HLA complex; Host response; Linkage analysis; Lymphatic filariasis

Indexed keywords

HLA ANTIGEN; PARASITE ANTIGEN;

BIODIVERSITY; DIAGNOSTIC APPROACH ROUTE; DISEASE PREDISPOSITION; FILARIASIS; GENE ISOLATION; GENE SEQUENCE; GENETIC LINKAGE; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HOST PARASITE INTERACTION; HUMAN; IMMUNE RESPONSE; INFECTION CONTROL; LYMPHATIC SYSTEM DISEASE; MALARIA; MORBIDITY; NONHUMAN; OUTCOMES RESEARCH; PARASITOSIS; POPULATION RESEARCH; PUBLIC HEALTH; REVIEW; RISK FACTOR; SCHISTOSOMIASIS; STATISTICAL SIGNIFICANCE; TREATMENT PLANNING; TROPICS; VACCINE PRODUCTION;

ANIMALS; ELEPHANTIASIS, FILARIAL; GENETIC PREDISPOSITION TO DISEASE; HLA ANTIGENS; HUMANS; IMMUNITY, NATURAL; LINKAGE (GENETICS); VARIATION (GENETICS);

EID: 0037949011     PISSN: 14737159     EISSN: None     Source Type: Journal    
DOI: 10.1586/14737159.3.3.367     Document Type: Review

References (79)

1. Michael E. The population dynamics and epidemiology of lymphatic filariasis. In: Lymphatic Filariasis. Tropical Medicine: Science and Practice (Volume 1). Nutman T (Ed.). Imperial College Press, London, UK, 41-82 (2000).
2. Nutman TB, Kumaraswami V. Regulation of the immune response in lymphatic filariasis: perspectives on acute and chronic infection with Wuchereria bancrofti in South India. Parasite Immunol. 23, 389-399 (2001).
3. Kumaraswami V. The clinical manifestations of lymphatic filariasis. In: Lymphatic Filariais. Tropical Medicine: Science and Practice (Volume 1). Nutman T (ed.). Imperial College Press, London, UK, 103-126 (2000).
4. Freedman DO, Nutman TB, Ottesen EA. Protective immunity in bancroftian filariasis. Selective recognition of a 43-kDa larval stage antigen by infection-free individuals in an endemic area. J. Clin. Invest. 83, 14-22 (1989).
5. Dreyer G, Noroes J, Figueredo-Silva J, Piessens WF. Pathogenesis of lymphatic disease in bancroftian filariasis: a clinical perspective. Parasitol. Today 16, 544-548 (2000). Comprehensive review on the pathogenesis of lymphatic filariasis emphasizing factors that influence its clinical outcome.
6. Hoerauf A, Volkmann L, Hamelmann C et al. Endosymbiotic bacteria in worms as targets for a novel chemotherapy in fflariasis. Lancet 355, 1242-1243 (2000).
7. Maizels RM, Gomez-Escobar N, Gregory WF, Murray J, Zang X. Immune evasion genes from filarial nematodes. Int. J. Parasitol. 31, 889-898 (2001). Addresses molecular basis of immune evasion by Brugia malayi and specifically the long coevolutionary relationship between hosts and parasites in filarial infections.
8. Maizels RM, Allen JE, Yaszdanbakhsh M. Immunology of lymphatic filariasis: current controversies. In: Lymphatic Filariasis. Tropical Medicine: Science and Practice (Volume 1). Nutman T (Ed.). Imperial College Press, London, UK, 217 (2000).
9. Terhell AJ, Houwing-Duistermaat JJ, Ruiterman Y, Haarbrink M, Abadi K, Yazdanbakhsh M. Clustering of Brugia malayi infection in a community in South-Sulawesi, Indonesia. Parasitology 120 (Pt 1), 23-29 (2000).
10. Fanning MM, Kazura JW. Genetic association of murine susceptibility to Brugia malayi microfilaraemia. Parasite Immunol. 5, 305-316 (1983).
11. Donfack J, Ngu JL, Lando G, Zimmerman PA, Nutman J, Same-Ekobo A. Variations under genetic control of onchocerca infection as a function of clinical profile in the endemic center of Cameroon. Bull. Soc. Pathol. Exot. 92, 85-90 (1999).
12. Hoerauf A, Brattig N. Resistance and susceptibility in human onchocerciasis-beyond Th1 versus Th2. Trends Parasitol. 18, 25-31 (2002).
13. Folkard SG, Bianco AE. The effects of H2 and non-H2 genes on the survival of Onchocerca lienalis microfilariae in the mouse. Parasite Immunol. 17, 329-333 (1995). An early study that provides evidence supporting genetic influence on the survival of microfilariae. Demonstrated significant differences of parasite recoveries after establishment of primary microfilaremia in a mouse model.
14. Klion AD, Massougbodji A, Sadeler BC, Ottesen EA, Nutman TB. Loiasis in endemic and nonendemic populations: immunologically mediated differences in clinical presentation. J. Infect. Dis. 163, 1318-1325 (1991).
15. Garcia A, Abel L, Cot M et al. Longitudinal survey of Loa loa filariasis in southern Cameroon: long-term stability and factors influencing individual microfilarial status. Am J. Trop. Med Hyg. 52, 370-375 (1995).
16. Allen JE, Maizels RM. Immunology of human helminth infectin. Int. Arch. Allergy Immunol. 109, 3-10 (1996).
17. Williams SA, Johnston DA. Helminth genome analysis: the current status of the filarial and schistosome genome projects: Filarial Genome Project and Schistosome Genome Project. Parasitology 118(Suppl.), S19-S38 (1999).
18. Williams SA, Lizotte-Waniewski MR, Foster J et al. The filarial genome project: analysis of the nuclear, mitochondrial and endosymbiont genomes of Brugia malayi. Int. J. Parasitol. 30, 411-419 (2000). Update on the Filarial Genome Project, primarily focused on the B. malayi organism Over 7000 Brugia genes have been identified. Provides the foundation for development of potential vaccines and drug targets.
19. Blaxter M, Daub J, Guiliano D, Parkinson J, Whitton C. The Brugia malayi genome project: expressed sequence tags and gene discovery. Trans. R. Soc. Trop. Med Hyg. 96, 7-17 (2002).
20. Taylor JG, Choi EH, Foster CB, Chanock SJ. Using genetic variation to study human disease. Trends Mol. Med. 7, 507-512 (2001). Concise review presenting the outline of two different main approaches to investigate genetic association in human diseases.
21. Risch NJ. Searching for genetic determinants in the new millennium. Nature 405, 847-856 (2000).
22. Sham P, Bader JS, Craig I, O'Donovan M, Owen M. DNA pooling: a tool for large-scale association studies. Nature Rev. Genet. 3, 862-871 (2002).
23. Botstein D, Risch N. Discovering genotypes underlying human phenotypes: past successes for Mendelian disease, future approaches for complex disease. Nature Genet. 33(Suppl.), 228-237 (2003).
24. Risch N, Merikangas K. The future of genetic studies of complex human diseases. Science 273, 1516-1517 (1996).
25. Hirschhorn JN, Lohmueller K, Byrne E, Hirschhorn K. A comprehensive review of genetic association studies. Genet. Med. 4, 45-61 (2002).
26. Dahlman I, Eaves IA, Kosoy R et al. Parameters for reliable results in genetic association studies in common disease. Nature Genet. 30, 149-150 (2002).
27. Cardon LR, Bell JI. Association study designs for complex diseases. Nature Rev. Genet. 2, 91-99 (2001).
28. Peltonen L, McKusick VA. Genomics and medicine. Dissecting human disease in the postgenomic era. Science 291, 1224-1229 (2001).
29. Chakravard A. To a future of genetic medicine. Nature 409, 822-823 (2001).
30. Chanock SJ. Candidate genes and single nucleotide polymorphisms (SNPs) in the study of human disease. Dis. Markers 17, 89-98 (2001).
31. Reich DE, Cargill M, Bolk S et al. Linkage disequilibrium in the human genome. Nature 411, 199-204 (2001).
32. Sabeti PC, Reich DE, Higgins JM et al. Detecting recent positive selection in the human genome from haplotype structure. Nature419, 832-837 (2002).
33. Chanock SJ, Foster CB. SNPing away at innate immunity. J. Clin. Invest. 104, 369-370 (1999).
34. Hill AV, Allsopp CE, Kwiatkowski D et al. Common west African HLA antigens are associated with protection from severe malaria. Nature 352, 595-600 (1991).
35. Hill AV, Elvin J, Willis AC et al. Molecular analysis of the association of HLA-B53 and resistance to severe malaria. Nature 360, 434-439 (1992).
36. Ruwende C, Khoo SC, Snow RW et al. Natural selection of hemi- and heterozygotes for G6PD deficiency in Africa by resistance to severe malaria. Nature 376, 246-249 (1995).
37. McGuire W, Hill AV, Allsopp CE, Greenwood BM, Kwiatkowski D. Variation in the TNF-α promoter region associated with susceptibility to cerebral malaria. Nature 371, 508-510 (1994).
38. McGuire W, Knight JC, Hill AV et al. Severe malarial anemia and cerebral malaria are associated with different tumor necrosis factor promoter alleles. J. Infect. Dis. 179, 287-290 (1999).
39. Knight JC, Udalova I, Hill AV et al. A polymorphism that affects OCT-1 binding to the TNF promoter region is associated with severe malaria. Nature Genet. 22, 145-150 (1999).
40. Marquet S, Abel L, Hillaire D et al. Genetic localization of a locus controlling the intensity of infection by Schistosoma mansoni on chromosome 5q31-q33. Nature Genet. 14, 181-184 (1996).
41. Garcia A, Marquet S, Bucheton B et al. Linkage analysis of blood Plasmodium falciparum levels: interest of the 5q31-q33 chromosome region. Am. J. Trap. Med. Hyg. 58, 705-709 (1998).
42. Abel L, Cot M, Mulder L Carnevale P, Feingold J. Segregation analysis detects a major gene controlling blood infection levels in human malaria. Am. J. Hum. Genet. 50, 1308-1317 (1992).
43. Abel L, Demenais F, Prata A, Souza AE, Dessein A. Evidence for the segregation of a major gene in human susceptibility/ resistance to infection by Schistosoma mansoni. Am. J. Hum. Genet. 48, 959-970 (1991).
44. Ottesen EA, Mendell NR, MacQueen JM, Weller PF, Amos DB, Ward FE. Familial predisposition to filarial infection not linked to HLA-A or-B locus specificities. ACTA Trop. 38, 205-216 (1981). Demonstration of familial clustering in lymphatic filariasis in a large familial study. Suggests the likelihood of genetic contributions other than HLA-A or B.
45. Noireau F, Pichon G. Population dynamics of Loa loa and Mansonella perstans infections in individuals living in an endemic area of the Congo. Am. J. Trop. Med. Hyg. 46, 672-676 (1992).
46. Garcia A, Abel L, Cot M et al. Genetic epidemiology of host predisposition microfilaraemia in human loiasis. Trop. Med. Int. Health 4, 565-574 (1999). Well conducted familial study on genetic predisposition in human loiasis. Segregation analysis indicated a potential genetic control of microfilaremia.
47. The MHC Sequencing Consortium. Complete sequence and gene map of a human major histocompatibility complex. Nature 401, 921-923 (1999).
48. Hughes AL Strength in numbers. Nature 417, 795 (2002).
49. Chan SH, Dissanayake S, Mak JW et al. HLA and filariasis in Sri Lankans and Indians. Southeast Asian J. Trap. Med. Public Health 15, 281-286 (1984). Association of HLA B15 with the susceptibility to dephantiasis was demonstrated.
50. Romia SA, el-Ganayni GA, Makhlouf LM, Handousa AE. HLA antigens and blood groups in bancroftian filariasis. J. Egypt Soc. Parasitol. 18, 211-220 (1988). Identifies an association between HLA B5 and B16 and susceptibility to bancroftian filariasis.
51. Yazdanbakhsh M, Sartono E, Kruize YC et al. HLA and elephantiasis in lymphatic filariasis. Hum. Immunol. 44, 58-61 (1995). Provides evidence that the immune response can be modulated by HLA class II antigens in elephantiasis. In particular, HLA DQ5 positive individuals had increased antifilarial IgG3 levels.
52. Brattig NW, Tischendorf FW, Reifegerste S, Albiez EJ, Berger J. Differences in the distribution of HLA antigens in localized and generalized form of onchocerciasis. Trop. Med. Parasitol. 37, 271-275 (1986).
53. Meyer CG, Gallin M, Erttmann KD et al. HLA-D alleles associated with generalized disease, localized disease and putative immunity in O. volvulus infection. Proc. Natl Acad. Sci. USA 91, 7515-7519 (1994). Suggests that HL4-D variants influence the outcome of Onchocerca volvulus infection.
54. Murdoch ME, Payton A, Abiose A et al. HLA-DQ alleles associate with cutaneous features of onchocerciasis. The Kaduna- London-Manchester Collaboration for Research on Onchocerciasis. Hum. Immunol. 55, 46-52 (1997).
55. King CL, Nutman TB. Regulation of the immune response in lymphatic filariasis and onchocerciasis. Immunol. Today 12, A54-A58 (1991).
56. de Vries RR, Meera Khan P, Bernini LF, van Loghem E, van Rood JJ. Genetic control of survival in epidemics. J. Immunogenet. 6, 271-287 (1979).
57. Propert D. Immunoglobulin allotypes and RFLPs in disease association. Exp. Clin. Immunogenet. 12, 198-205 (1995).
58. Whittingham S, Propert DN. GM and KM allotypes, immune response and disease susceptibility. Monogr. Allergy 19, 52-70 (1986).
59. Pandey JP, Elson LH, Sutherland SE, Guderian RH, Araujo E, Nutman TB. Immunoglobulin κ chain allotypes (KM) in onchocerciasis. J Clin. Invest. 96, 2732-2734 (1995). Demonstrates that immunoglobulin (KM) allotypes are assodated with susceptibility to onchocerciasis.
60. Kron MA, Ramirez B, Belizario V Jr, Pandey JP. Immunoglobulin allotypes among the Bicolanos of Sorsogon province, Luzon, Philippines: implications of phenotypes for filariasis. Exp. Clin. Immunogenet. 16, 65-71 (1999).
61. Choi EH, Zimmerman PA, Foster CB et al. Genetic polymorphisms in molecules of innate immunity and susceptibility to infection with Wuchereria bancrofti in South India. Genes Immun. 2, 248-253 (2001). Investigates nonHLA host genetic factors in lymphatic filariasis and identified two potential genes in the innate immune pathway associated with susceptibility to filarial infection.
62. Boot RG, Renkema GH, Verhoek M et al. The human chitotriosidase gene. Nature of inherited enzyme deficiency. J. Biol. Chem. 273, 2568O-25685 (1998).
63. Dissanayake S, Perler FB, Xu M et al. Differential recognition of microfilarial chitinase, a transmission-blocking vaccine candidate antigen, by sera from patients with Brugian and Bancroftian filariasis. Am. J. Trop. Med. Hyg. 53, 289-294 (1995).
64. Adam R, Kaltmann B, Rudin W, Friedrich T, Marti T, Lucius R. Identification of chitinase as the immunodominant filarial antigen recognized by sera of vaccinated rodents. J. Biol. Chem. 271, 1441-1447 (1996).
65. Wang SH, Zheng HJ, Dissanayake S et al. Evaluation of recombinant chitinase and SXP1 antigens as antimicrofilarial vaccines. Am. J. Trop. Med. Hyg. 56, 474-481 (1997).
66. Devaney E. Lectin-binding characteristics of Brugia pahangi microfilariae. Trop. Med. Parasitol. 36, 25-28 (1985).
67. Hoppe HJ, Reid KB. Trimeric C-type lectin domains in host defence. Structure 2, 1129-1133 (1994).
68. Turner MW. Mannose-binding lectin: the pluripotent molecule of the innate immune system. Immunol. Today 17, 532-540 (1996).
69. Madsen HO, Garred P, Kurtzhals JA et al. A new frequent allele is the missing link in the structural polymorphism of the human mannan-binding protein. Immunogenetics 40, 37-44 (1994).
70. Madsen HO, Gaffed P, Thiel S et al. Interplay between promoter and structural gene variants control basal serum level of man-binding protein. J Immunol. 155, 3013-3020 (1995).
71. Garred P, Richter C, Andersen AB et al. Mannan-binding lectin in the sub-Saharan HIV and tuberculosis epidemics. Scand. J. Immunol. 46, 204-208 (1997).
72. Foster CB, Lehrnbecher T, Mol F et al. Host defense molecule polymorphisms influence the risk for immune-mediated complications in chronic granulomatous disease. J. Clin. Invest. 102, 2146-2155 (1998).
73. Garred P, Pressler T, Madsen HO et al. Association of mannose-binding lectin gene heterogeneity with severity of lung disease and survival in cystic fibrosis. J. Clin. Invest. 104, 431437 (1999).
74. Ottesen EA. Immune responsiveness and the pathogenesis of human onchocerciasis. J. Infect. Dis. 171, 659471 (1995).
75. Hoerauf A, Kruse S, Brattig NW, Heinzmann A, Mueller-Myhsok B, Deichmann KA. The variant Arg110Gln of human IL-13 is associated with an immunologically hyperreactive form of onchocerciasis (sowda). Microbes Infect. 4, 3742 (2002). Demonstrated an association between the rare phenotype sowda of onchocerciasis and a nonsynonymous SNP of IL13 using the candidate gene approach.
76. Nutman TB, Kumataswami V, Ottesen EA. Parasite-specific anergy in human filariasis. Insights after analysis of parasite antigen-driven lymphokine production. J. Clin. Invest. 79, 1516-1523 (1987).
77. Mahanty S, Nutman TB. Immunoregulation in human lymphatic filariasis: the role of interleukin-10. Parasite Immunol. 17, 385-392 (1995).
78. Choi EH, Lee HJ, Yoo T, Chanock SJ. A common haplotype of interleukin-4 gene (IL4) is associated with severe respiratory syncytial virus disease in Korean children. J. Infect. Dis. 186, 1207-1211 (2002).
79. Choi EH, Foster CB, Taylor JG et al. Association between chronic disseminated candidiasis in adult acute leukemia and common IL4 promoter haplotypes. J. Infect. Dis. 187, 1153-1156 (2003).